For patients with solid tumors without known bone marrow involvement:
For patients with solid tumors without known bone marrow involvement:
For patients with solid tumors without known bone marrow involvement: peripheral absolute neutrophil count (ANC) >= /mm^
Peripheral absolute neutrophil count (ANC) >= /uL for patients with solid tumors without bone marrow involvement
Peripheral absolute neutrophil count (ANC) >= /uL for patients with solid tumors and known bone marrow metastatic disease
Platelet count >= ,/uL for patients with solid tumors and known bone marrow metastatic disease
Within  days of treatment initiation: Absolute neutrophil count (ANC) >=  cells/mm^ (or >=  in subjects with bone marrow involvement)
Absolute neutrophil count (ANC) >= /uL for subjects without bone marrow involvement
For patients with solid tumors without known bone marrow involvement:
Absolute neutrophil count (ANC) ? /uL\r\n* The above criteria do not have to be met if the patient has bone marrow involvement of tumor
Subjects must have adequate Bone Marrow function defined as: For patients without bone marrow involvement:  Peripheral absolute neutrophil count (ANC) >/uL
Absolute neutrophil count >= /mm^ in the absence of bone marrow involvement; patients with bone marrow involvement are not required to have a minimum absolute neutrophil count
For subjects with solid tumors without known bone marrow involvement: peripheral absolute neutrophil count (ANC) >= /mm^
Absolute neutrophil count (ANC) >= . x ^/L or < . x ^/L but >= . due to > % marrow involvement\r\n* Patients who entered the trial prior to June ,  were restricted to > % marrow involvement
Bone marrow function: absolute neutrophil count ?,/L, and platelets ? ,/ L;
For subjects with solid tumors without known bone marrow involvement: \r\n*Peripheral absolute neutrophil count (ANC) ? /mm^
Absolute neutrophil count (ANC) >= , /mcL if no bone marrow involvement, ANC >=  /mcL if documented bone marrow involvement
For patients with solid tumors without bone marrow involvement: peripheral absolute neutrophil count (ANC) >= /uL
For patients with solid tumors and known bone marrow metastatic disease: peripheral absolute neutrophil count (ANC) >= /uL
For patients with solid tumors without bone marrow involvement: peripheral absolute neutrophil count (ANC) >= /mm^
For patients with solid tumors without known bone marrow involvement: peripheral absolute neutrophil count (ANC) >= /mm^
Absolute neutrophil count (ANC) >= ,/uL unless due to bone marrow involvement
Part : absolute neutrophil count (ANC) >= . x ^/L; Part : ANC >= . x ^/L if there is bone marrow involvement, >= . x ^/L if there is no bone marrow involvement
PART B: FOR PATIENTS WITHOUT KNOWN BONE MARROW INVOLVEMENT
absolute neutrophil count >,/?L in absence of bone marrow involvement
Absolute neutrophil count (ANC) >= ,; patients with bone marrow involvement are allowed at the investigators discretion regardless of cytopenias
Absolute Neutrophil Count (ANC) ? . x /L or ? . x /L (with bone marrow involvement with DLBCL)
